Gan & Lee Insulin Glargine Target Type (2) Evaluating Research

PHASE3CompletedINTERVENTIONAL
Enrollment

567

Participants

Timeline

Start Date

October 31, 2017

Primary Completion Date

April 17, 2019

Study Completion Date

April 17, 2019

Conditions
Diabetes Mellitus, Type 2
Interventions
BIOLOGICAL

Gan & Lee Insulin Glargine Injection

Route of administration: subcutaneous injection

BIOLOGICAL

Lantus®

Route of administration: subcutaneous injection

Trial Locations (57)

22105

Burke Internal Medicine & Research, Burke

27834

Physicians East, PA, Greenville

29651

Mountain View Clinical Research, Greer

30030

iResearch Atlanta, Decatur

30060

Sestron Clinical Research, Marietta

30076

Endocrine Research Solutions, Inc., Roswell

30513

River Birch Research Alliance, LLC, Blue Ridge

32174

Peninsula Research, Ormond Beach

32765

Oviedo Medical Research, Oviedo

33032

Homestead Associates in Research, Homestead

33155

Biotech Pharmaceutical Group, LLC, Miami

33165

Genoma Research Group, Miami

33175

New Horizon Research Center, Miami

33176

Miami Dade Medical Research Institute, LLC, Miami

33312

The Center for Diabetes and Endocrine Care, Fort Lauderdale

33401

Metabolic Research Institute, West Palm Beach

34201

Meridien Research, Bradenton

34652

Suncoast Clinical Research, Inc., New Port Richey

35211

Simon Williamson Clinic, Birmingham

35674

Terence T. Hart, MD, Tuscumbia

37411

University Diabetes & Endocrine Consultants, Chattanooga

37421

ClinSearch - Clinical Research Specialists, Chattanooga

37909

New Phase Research & Development, Knoxville

40213

L-MARC Research Center, Louisville

43201

Endocrinology Associates, Inc., Columbus

45419

PriMed Clinical Research, Dayton

50265

Iowa Diabetes and Endocrinology Research Center, West Des Moines

53144

Clinical Investigations Specialists-Wisconsin, Kenosha

58104

Lillestol Research LLC, Fargo

60012

Midwest CRC, Crystal Lake

60607

Cedar Crosse Research Center, Chicago

60612

John H. Stroger Jr. Hospital of Cook County, Chicago

78028

Sante Clinical Research, Kerrville

78154

Northeast Clinical Research of San Antonio, Schertz

78229

Clinical Trials of Texas, San Antonio

78681

Texas Diabetes & Endocrinology - Round Rock, Round Rock

78726

Austin Regional Clinic, Austin

78749

Texas Diabetes & Endocrinology - South Austin, Austin

84088

Advanced Clinical Research, West Jordan

84107

Wasatch Clinical Research, LLC, Salt Lake City

84123

Radiant Research, Murray

85018

Family Practice Specialists, Phoenix

89128

Palm Research Center, Inc., Las Vegas

91324

California Medical Research Association, Northridge

92657

The Rose Salter Medical Research Foundation, Newport Coast

93720

Valley Research, Fresno

95821

Northern California Research Corp., Sacramento

96814

East-West Medical Research Institute, Honolulu

98003

Stonesifer Clinical Research, Federal Way

98057

Rainier Clinical Research Center, Inc., Renton

35294-3407

University of Alabama at Birmingham, Birmingham

06517

CMR of Greater New Haven, LLC, Hamden

06708

Chase Medical Research, LLC, Waterbury

40503-1473

Kentucky Diabetes Endocrinology Center, Lexington

01844

ActivMed Practices and Research - Methuen, Methuen

43213-6523

Aventiv Research, Inc., Columbus

78731-4309

Texas Diabetes & Endocrinology - Central Austin, Austin

All Listed Sponsors
lead

Gan and Lee Pharmaceuticals, USA

INDUSTRY